
Sign up to save your podcasts
Or


Breadth was solid again with winners beating losers on the Nasda by about 2 to 1. The ratio was nearly 3 to 1 positive on the NYSE. Annual nonfarm payrolls were revised lower by 818,000, but the stock market took the news in stride. Procept soared after the company received FDA clearance for a next-generation surgical robot; Applovin is near the top of a short consolidation; Birkenstock is still in a buy zone ahead of next week’s earnings report.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Investor's Business Daily4.7
3636 ratings
Breadth was solid again with winners beating losers on the Nasda by about 2 to 1. The ratio was nearly 3 to 1 positive on the NYSE. Annual nonfarm payrolls were revised lower by 818,000, but the stock market took the news in stride. Procept soared after the company received FDA clearance for a next-generation surgical robot; Applovin is near the top of a short consolidation; Birkenstock is still in a buy zone ahead of next week’s earnings report.
Learn more about your ad choices. Visit megaphone.fm/adchoices

3,218 Listeners

1,369 Listeners

1,499 Listeners

946 Listeners

516 Listeners

351 Listeners

296 Listeners

1,417 Listeners

1,035 Listeners

343 Listeners

379 Listeners

302 Listeners

1,552 Listeners

208 Listeners

66 Listeners